Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARBOPLATIN Cause Drug ineffective? 3,377 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 3,377 reports of Drug ineffective have been filed in association with CARBOPLATIN (Carboplatin). This represents 4.0% of all adverse event reports for CARBOPLATIN.

3,377
Reports of Drug ineffective with CARBOPLATIN
4.0%
of all CARBOPLATIN reports
854
Deaths
802
Hospitalizations

How Dangerous Is Drug ineffective From CARBOPLATIN?

Of the 3,377 reports, 854 (25.3%) resulted in death, 802 (23.7%) required hospitalization, and 282 (8.4%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARBOPLATIN. However, 3,377 reports have been filed with the FAERS database.

What Other Side Effects Does CARBOPLATIN Cause?

Off label use (6,100) Neutropenia (5,314) Anaemia (5,312) Febrile neutropenia (4,888) Nausea (4,588) Disease progression (4,538) Thrombocytopenia (4,483) Malignant neoplasm progression (4,177) Diarrhoea (4,154) Dyspnoea (3,494)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which CARBOPLATIN Alternatives Have Lower Drug ineffective Risk?

CARBOPLATIN vs CARBOPROST TROMETHAMINE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\GLYCERIN\POLYSORBATE 80 CARBOPLATIN vs CARBOXYMETHYLCELLULOSE\HYPROMELLOSES

Related Pages

CARBOPLATIN Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective CARBOPLATIN Demographics